Skip to content

2223111

by Nordic Group B.V.

Ref 2223111Model Lacrifill® Procedure Pack

Active European Union

CE MDR

Valid until

Not listed

EUDAMED holds no validity date

FDA recalls

Not applicable

No FDA record for this device

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source EUDAMED, synced 23 Oct 2026. What this means

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number871848114LACPACKQL Basic UDI-DI 08718481147269UDI-DIDate10 Jun 2026RegisteredStatusActive

Certificates

0 certificates · EUDAMED

EUDAMED lists no certificate for this device's Basic UDI-DI.

A certificate issued for a device group may exist without being linked here.

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/MDR Active

Specification

EUDAMED

Model / Reference
Lacrifill® Procedure Pack, 2223111
Primary DI / UDI-DI
08718481147269
Basic UDI-DI
871848114LACPACKQL
EMDN Code
Q020702 Lacrimal duct occluders
Device Class
Class IIb
Medical Purpose
Lacrifill® procedure pack to help insertion of the gel. Lacrifill® is designed to temporarily block tear drainage by the occlusion of the lacrimal canaliculus of one or both eyelids in a given patient, thus maintaining lubricating tears on the surface of the eye. The cannula is intended to be used as an accessory to aid in the effective delivery of Lacrifill® into the lacrimal canaliculus.

Manufacturer details

EUDAMED SRN
NL-PR-000049988

Other devices from Nordic Group B.V.

See all devices from Nordic Group B.V. →

Properties

  • Sterile